REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Drug, Bio-affecting And Body Treating Compositions > Preparations Characterized By Special Physical Form > Capsules (e.g., Of Gelatin, Of Chocolate, Etc.) > Gelatin GelatinGelatin patent applications listed are from June 2005 to current and include Date, Patent Application Number, Patent Title, Patent Abstract summary and are linked to the corresponding patent application page.07/19/07 - 20070166374 - Composition and method for tissue repair and regeneration The present invention provides novel compositions and methods for protecting and promoting cell growth and restoring physiological structure and function to tissue or organ of the body, especially mucosa in the gastrointestinal tract. The composition can be used as a pharmaceutical or nutraceutical to treat a gastrointestinal disorder or to ... 07/12/07 - 20070160664 - Pharmaceutical compositions comprising of proton pump inhibitor and prokinetic agent Oral pharmaceutical compositions and process for preparation thereof are provided comprising at least one gastric acid suppressing agent, preferably a proton pump inhibitor or its pharmaceutically acceptable salts, esters, hydrates, derivatives or prodrugs, and one or more prokinetic agent or its pharmaceutically acceptable salts, esters, hydrates, derivatives or prodrugs, optionally ... 07/12/07 - 20070160663 - Single unit pharmaceutical composition comprising a mixture of fenofibrate and a modified release form of a homocysteine reducing agent An oral lipid lowering pharmaceutical unit form comprising a first solid or semi solid composition comprising fenofibrate and a second solid or semi solid composition comprising at least a modified release form of an homocysteine lowering agent. ... 05/24/07 - 20070116757 - Methylene blue derivatives Pharmaceutical compositions comprising a fatty acid salt, a dicarboxylic acid salt, an alkyl sulfate salt, an aryl sulfate salt or an alkyl aryl sulfonate salt of methylene blue or a derivative of methylene blue are described herein. The compositions are preferably administered orally and can be administered as tablets, soft ... 05/10/07 - 20070104781 - Hypocholesteremic preparations containing mixtures of phytostenol(ester)s and conjugated fatty acids, and methods of using the same A hypocholesteremic preparation containing at least one component (a) selected from the group consisting of phytostenols and phytostenol esters and at least one component (b) selected from conjugated fatty acids having from about 6 to about 24 carbon atoms and glycerides of conjugated fatty acids having from about 6 to ... 05/10/07 - 20070104780 - Formulation comprising a drug of low water solubility and method of use thereof A pharmaceutical composition comprises a drug-carrier system having a small-molecule drug of low water solubility, e.g. N-[4-(3-amino-1H-indazol-4-yl)phenyl]-N′-(2-fluoro-5-methylphenyl)urea (ABT-869), and (+)-1-(5-tert-butyl-1-yl)-3-(1H-indazol-4-yl)-urea (ABT-102), in solution in a substantially non-aqueous carrier that comprises at least one phospholipid and a pharmaceutically acceptable solubilizing agent. The drug-carrier system, when mixed with an aqueous phase, typically ... 05/10/07 - 20070104779 - Treatment with omega-3 fatty acids and products thereof A method for reducing non-HDL cholesterol levels of a subject comprising administering a pharmaceutical composition comprising omega-3 fatty acids to the subject in an amount sufficient to reduce non-HDL cholesterol. The method may include a reduction of the triglyceride levels of the subject and, optionally, an increase in the HDL ... 05/03/07 - 20070098786 - Enteric valproic acid An enteric valproic acid soft gelatin capsule, in which the enteric polymer is a component of the capsule shell rather than a coating, has been developed. The fill material comprises valproic acid or divalproex sodium and, optionally, one or more pharmaceutically acceptable excipients such as corn oil. The capsule shell ... 04/12/07 - 20070082046 - Enteric valproic acid An enteric valproic acid soft gelatin capsule, in which the enteric polymer is a component of the capsule shell rather than a coating, has been developed. The fill material comprises valproic acid or divalproex sodium and, optionally, one or more pharmaceutically acceptable excipients such as corn oil. The capsule shell ... 03/29/07 - 20070071809 - Ginger containing compositions to control pain Pain is controlled by ingesting a composition comprising at least about 510 mg of ginger, at least about 1000 mg of glucosamine and at least about 1200 mg of chondroitin sulfate or methylsulfonylmethane, all weights based on a total daily dosage of the composition. ... 03/22/07 - 20070065504 - Products and methods for treating vaginal infections The methods of the invention treat vaginal fungal and yeast infections. More particularly, according to the methods of the invention, solid dosage forms may be administered to patients to treat vaginal fungal and yeast infections subsequent to awakening at any time during the day more than thirty minutes prior to ... 03/08/07 - 20070053972 - Gelatin capsules containing actives Gelatin capsules are surface treated with compositions which provide enhanced protection to the actives within by imparting one or more properties such as increased hardeners to the gelatin shell, an enhanced protective barrier or enhanced organoleptic perception to the consumer. ... 03/01/07 - 20070048367 - Herbal composition for treating morning sickness An herbal composition for treating morning sickness includes a mixture of vitamin B6, folic acid, ginger root extract, and red raspberry leaf. ... 03/01/07 - 20070048366 - Gelatin-based coatings having improved durability The present invention relates to a process for manufacturing gelatin products that have improved stability, particularly as to the dissolution rates and/or reduced degree of crosslinking and the gelatin formulations per se. A further aspect of the invention is use of the improved gelatin compositions for use as a coating ... 02/22/07 - 20070042037 - Pharmaceutical composition containing levodopa and carbidopa An oral solid pharmaceutical composition for constant and prolonged release of a levodopa/carbidopa combination, for use in the treatment of Parkinson disease. ... 02/15/07 - 20070036850 - Film-coated tablet or granules containing as active ingredient a pyridylpyrimidine compound or a pharmaceutically acceptable salt of this compound Film-coated tablet, consisting of a tablet core with a film coating, or granules containing as active ingredient a pyridylpyrimidine compound or a pharmaceutically acceptable salt of this compound, preferably imatinib or a pharmaceutically acceptable salt of imatinib, preferably imatinib monomethanesulfonate, wherein (i) the tablet cores and the granules have been ... 02/08/07 - 20070031487 - Nutritional supplement for women A composition for the nutritional supplementation of women and a method of administering a composition designed for the nutritional supplementation of women is described. ... 01/25/07 - 20070020328 - Probiotics as alternative medicines against infectious diseases An exemplary embodiment providing one or more improvements includes feeding animals with probiotic microbes encapsulated in a mixture of xanthan gum and chitosan, or in gelatin, specifically Pediococcus acidilactici and Saccharomyces boulardii. Such encapsulation protects the viability of the probiotic microbes against unfavorable temperatures. An exemplary embodiment providing one or ... 01/18/07 - 20070014849 - Use of ramoplanin to treat diseases associated with the use of antibiotics The invention features a method of treating or preventing a disease associated with the use of antibiotics in a patient in need thereof by administering to the patient ramoplanin in an amount and for a duration effective to treat said disease. The disease may be caused, for example, by the ... 01/18/07 - 20070014848 - Resorbable polyetheresters and medicinal implants made therefrom The invention relates to the use of absorbable block copolymers with polyether and polyester units for preparing surgical implants which are suitable for the human or animal body, and the block copolymers in question. The block copolymers used according to the invention and those which are new according to the ... 01/04/07 - 20070003614 - Pharmaceutical compositions comprising active vitamin d compounds Disclosed are pharmaceutical compositions comprising an active vitamin D compound in emulsion pre-concentrate formulations, as well as emulsions and sub-micron droplet emulsions produced therefrom. The compositions comprise a lipophilic phase component, one or more surfactants, and an active vitamin D compound. The compositions may optionally further comprise a hydrophilic phase ... 12/28/06 - 20060292217 - Nutritional supplement and soft gelatin capsule delivery system A nutritional composition and method of introducing the composition into a soft gelatin capsule. The composition includes effective amounts of omega-3 fatty acid, vitamin D and selenium. The method includes forming each component into a unitary form, forming a soft gelatin capsule and introducing the unitary composition into the capsule. ... 12/28/06 - 20060292216 - Enteric delivery of (-)-hydroxycitric acid The present invention provides stable encapsulated (−)-hydroxycitric acid (“HCA”) dosage unit forms, uses thereof, as well as and methods of making the same. In particular, HCA and the salts, esters and amides of HCA according to the invention are delivered via enteric vehicles, such as enteric-coated tablets, and also enteric ... 12/21/06 - 20060286164 - Pharmaceutical composition containing a stable and clear solution of anti-inflammatory drug in soft gelatin capsule and process for producing the same Disclosed herein is a pharmaceutical composition comprising a soft gelatin capsule containing a clear and stable solution of sodium dihydratate salt of ibuprofen by employing a system of solubilizer, co-solubilizer and antioxidants. ... 12/07/06 - 20060275361 - Rapidly dissolving gelatin compositions and products made therefrom Rapidly dissolving gelatin compositions and products made therefrom are disclosed. The gelatin compositions and products exhibit controllable dissolution speeds, and particularly faster dissolution times through the incorporation of one or more dissolution enhancing materials. ... 11/30/06 - 20060269598 - Antihistaminic/decongestant/anticholinergic compositions and methods of use Compositions comprising essentially of methscopolamine in combination with tannate compounds which are effective when administered orally for the symptomatic relief of symptoms associated with upper respiratory tract conditions such as the common cold, sinusitis, allergic rhinitis, and other upper respiratory tract conditions. ... 11/30/06 - 20060269597 - Tannate compositions and methods of use for the treatment of respiratory tract conditions Compositions comprising essentially of methscopolamine tannate alone or in combination with other tannate compounds which are effective when administered orally for the symptomatic relief of symptoms associated with upper respiratory tract conditions such as the common cold, sinusitis, allergic rhinitis, and other upper respiratory tract conditions. ... 11/30/06 - 20060269596 - Controlled release compositions comprising an acylanilide The invention relates to a controlled release composition comprising acylanilide, and preferably bicalutamide, for use, in particular, in combination therapy with a luteinizing hormone-releasing hormone (LHRH) analogue for the treatment of stage D2 metastatic carcinoma of the prostate. The controlled release composition comprises an immediate release component and a modified ... 10/26/06 - 20060240099 - High-amylose starch The subject of the present invention is a process for preparing pregelatinized high amylose starch, having the steps consisting of: forming a suspension comprising a high amylose starch and water; subjecting the suspension to steam jet cooking at a temperature of between 125 and 135° C. so as to obtain ... 10/26/06 - 20060240098 - Formulations for hyperforin-enriched hypericum fractions St. John's Wort products which have enhanced bioactivity in a serotonin re-uptake assay and enhanced stability and bioavailability are formulated and manufactured from hyperforin-enriched Hypericum fractions made by supercritical and near critical fluids with and without polar cosolvents. These fluids are used to fractionate the biomass materials in several sequential ... 09/21/06 - 20060210622 - Surface modified particulate compositions of biologically active substances This invention disclosure relates to compositions for the delivery of stable surface modified sub-micron and micron sized particles of water-insoluble biologically active substances from a non-aqueous medium that self-disperses on exposure to an aqueous environment. ... 08/24/06 - 20060188567 - Gelatin hard capsule enhancing the film strength The present invention relates to a process for preparing gelatin hard capsule having enhanced film strength by the steps comprising; i) adding 1˜10 wt part of PEG mixture of PEG 600 and PEG 1500 in weight ratio 40˜60:60˜40 to the solution having 100 wt part of gelatin; ii) adding 0.1˜1.2 ... 08/17/06 - 20060182798 - Composition for gelatin coating, gelatin coating, and preparation using the same The present invention relates to a composition for gelatin coating and a gelatin coating characterized by containing a gelatin (A) and an inositol phosphate (B) represented by a general formula: C6H12-n.(H2PO4)n (in the formula, n represents an integer from 1 to 6), and a preparation using the same. ... 08/17/06 - 20060182797 - Sutained release formulation for venlafaxine hydrochloride The invention provides a sustained release composition that; 1. Is free of initially increased drug delivery that occurs (in sustained release systems containing the water soluble drug venlafaxine HCl, known as burst phenomenon, by using a functional core partially or totally coated by a functional coating layer or film. 2. ... 07/27/06 - 20060165778 - Enteric composition for the manufacture of soft capsule wall A gel mass is provided that is useful in manufacturing enteric soft or hard capsules, or enteric tablets without coating. ... 07/06/06 - 20060147518 - Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it This invention relates to solid and stable dispersions of a hydrosoluble derivative of vinca alkaloids in at least one polyethyleneglycol with a molecular mass between 800 and 30 000. ... 06/01/06 - 20060115526 - Venlafaxine compositions comprising pellets with double layer coating This invention provides coated pellets comprising a) a pellet core which comprises venlafaxine hydrochloride; b) a first coating which comprises a lipophilic layer or a sparingly water-soluble layer, and c) a second coating which comprises a water-insoluble polymer or polymer mixture. In another aspect this invention provides compositions which comprises ... 05/18/06 - 20060105034 - Formulation and delivery method to enhance antioxidant potency of vitamin e A formulation to deliver a full-spectrum of Vitamin E isomers for improved antioxidant capacity, bioavailability, dissolution and efficacy. The formulation includes dl-α-tocopheryl acetate or dl-α-tocopheryl succinate (synthetic Vitamin E), natural Vitamin E and mixed tocopherols, such as α-, β-, γ- and δ-tocopherol, as well as four isomers (α, β, γ ... 05/04/06 - 20060093664 - Natural vitamin e compositions with superior antioxidant potency Compositions for increased antioxidant potency of natural vitamin E (d-alpha-tocopherol), comprising alpha-, beta-, delta-, and gamma-forms of tocopherols and tocotrienols are disclosed. All of these compositions provide 400 International Units (IU), based on one mg of d-alpha-tocopherol provides 1.49 IU. These compositions showed antioxidant activities superior to natural d-alpha-tocopherol. These ... 04/27/06 - 20060088590 - Non-blooming gelatin and non-gelatin formulations A non-blooming plasticizer composition and methods of using the composition are described herein. The composition is a mixture of sorbitol and sorbitan wherein the ratio of sorbitan and sorbitol is between about 0.40 and about 1.2 by weight, more preferably from about 0.45-0.50 to about 0.70 by weight, wherein the ... 04/13/06 - 20060078608 - Flavored gelatin capsule and method for producing said capsule The present invention is directed to a flavored capsule suitable for encapsulating a dose and a method for making a flavored capsule. In one embodiment, a flavored capsule comprises a gelatin, water and a flavoring. The flavoring may be present in the flavored capsule in a concentration of between about ... 03/09/06 - 20060051409 - Bezonatate liquid hard capsule dosage form A pharmaceutical dosage includes a hard capsule, benzonatate and a sealer ring. The hard capsule has a bottom half and a top half that covers the bottom half. The benzonatate is in liquid form and is placed in the bottom half of the hard capsule. The sealer ring seals the ... 02/09/06 - 20060029661 - Orally administrable pharmaceutical formulation The present invention relates to pharmaceutical formulations for oral administration through a soft gelatin capsule, wherein the pharmaceutical dosage form has pseudoephedrine hydrochloride as the active pharmaceutical ingredient. The active pharmaceutical ingredient, pseudoephedrine hydrochloride as an active is embedded in a suitable matrix, wherein said matrix composition is characterized by ... 01/26/06 - 20060018958 - Coenzyme q10 formulation and process methodology for soft gel capsules manufacturing A formulation of Coenzyme Q10, beta-carotenes, Vitamin E, and medium chain triglycerides in rice bran oil and an optional thickener, such as bee's wax, is provided in a soft gel capsule so that a maximum of the Coenzyme Q10 is absorbed by the human body. Generally, about 60 mg of ... 12/29/05 - 20050287206 - Solubilized coq-10 and carnitine The present invention is directed to compositions and methods of delivery of CoQ-10 and an amino acid solubilized in monoterpenes. Use of monoterpenes as dissolving agents, greatly effects the ability to incorporate greater amounts of bioactive CoQ-10 and the amino acid, such as carnitine, i.e., carnitine tartrate, in formulations, such ... 11/10/05 - 20050249803 - Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols The present invention is directed to soft gel compositions, methods of delivery and packaged nutraceuticals of the soft gel compositions that include at least one polymethoxylated flavone and, optionally, at least one tocotrienol. ... 11/10/05 - 20050249802 - Softgel encapsulated pharmaceutical compositions comprising concentrated active ingredients The present invention is directed to pharmaceutical compositions which comprise highly concentrated pharmaceutical active and a stabilizing agent suspended in a solvent. These pharmaceutical compositions are suitable for encapsulation within soft gelatin capsules having improved stability. ... 10/06/05 - 20050220868 - Policosanol composition and its use in treatment of hypercholesterolemia A composition is provided containing at least 90% of policosanols obtained from rice bran wax, wherein the policosanols contain from about 25 to about 35% of octacosanol, and its use in providing significant improvements in total cholesterol and/or LDL reduction in subjects in need thereof. ... 09/29/05 - 20050214364 - Products and methods for treating vaginal infections The methods of the invention treat vaginal fungal and yeast infections. More particularly, according to the methods of the invention, solid dosage forms may be administered to patients to treat vaginal fungal and yeast infections subsequent to awakening at any time during the day more than thirty minutes prior to ... 09/15/05 - 20050202081 - Stable pharmaceutical compositions comprising ace inhibitor(s) The invention provides stable pharmaceutical compositions comprising ACE inhibitor(s) and other pharmaceutically active substances which are susceptible to degradation, as well as processes for the preparation thereof, and methods of treatment involving administration of such compositions. ... 08/18/05 - 20050181041 - Method of preparation of mixed phase co-crystals with active agents This invention pertains to a method of preparing mixed phase co-crystals of active agents with one or more materials that allows the modification of the active agent to a new physical/crystal form with unique properties useful for the delivery of the active agent, as well as compositions comprising the mixed ... 08/11/05 - 20050175686 - Drug delivery system using a solubilized gelatin shell composition and unit dose drug delivery using a special shape soft gelatin capsule Disclosed is an improved drug delivery device for delivering a fill pharmaceutical composition. The drug delivery device comprises a soft gelatin capsule having a shell comprising gelatin and plasticizer wherein the shell is dissoluble upon dispersion into warm water. The invention also discloses snip-off or twist-off soft gelatin capsules offering ... 08/04/05 - 20050169985 - Extended release formulation of venlafaxine hydrochloride The present invention relates to an extended release once daily pharmaceutical formulation comprising venlafaxine hydrochloride and pharmaceutically acceptable excipients. More particularly, the present invention relates to an extended release composition in the form of mini-tablets which are incorporated in hard gelatin capsules. ... 08/04/05 - 20050169984 - Pharmaceutical hard capsule containing inorganic substance The objective of the present invention is to improve the preservation stability of drugs filled within the hard capsule. Especially, the objective of the present invention is to improve the preservation stability of drugs filled within the hard gelatin capsule which base material is gelatin. The present invention provides a ... 08/04/05 - 20050169983 - Chewable soft capsule A matrix formulation for a soft chewable capsule is provided which includes a gel-forming composition, a plasticizer, a polymer modifier and water. The polymer modifier may be a carboxylic acid or other organic compound that alters the physical and/or chemical properties of the capsule formulation. A chewable soft capsule is ... 07/28/05 - 20050163834 - Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment The invention described herein relates to a pharmaceutical composition containing vinorelbine as an active ingredient which is suitable for encapsulation in soft capsules. The liquid oral pharmaceutical composition suitable for a liquid fill composition for a soft capsule dosage form comprises: vinorelbine or a pharmaceutically acceptable salt thereof; ethanol; water; ... 07/14/05 - 20050152971 - Rapidly disintegrating gelatinous coated tablets The present invention relates to an improved gelatinous coated dosage form having two end regions coated with gelatinous materials and an exposed circumferential band. Openings are provided in at least the exposed band to reveal the core material. The invention also relates to methods for manufacturing such gelatinous coated dosage ... 07/14/05 - 20050152970 - Rapidly disintegrating gelatinous coated tablets The present invention relates to an improved gelatinous coated dosage form having two end regions coated with gelatinous materials and an exposed circumferential band. Openings are provided in at least the exposed band to reveal the core material. The invention also relates to methods for manufacturing such gelatinous coated dosage ... 07/14/05 - 20050152969 - Colored liquid-filled soft capsules and method of manufacture thereof The present invention relates to a coated liquid-filled soft capsule containing a colored shell and method for making same. The shell material contains a colorant incorporated in the material in an amount sufficient to provide a visual contrast between the capsule shell and any liquid fill that escapes from the ... 07/07/05 - 20050147665 - Pharmaceutical and nutritional compositions The combined application of at least one essential fatty acid of the n-6 or n-3 series, optionally together with further essential fatty acid(s) of the n-6 or n-3 series, together with one or more homocysteine lowering agent. The homocysteine lowering agent is selected from vitamin B12, folic acid, a compound ... 06/30/05 - 20050142189 - Emulsion vehicle for poorly soluble drugs An emulsion of α-tocopherol, stabilized by biocompatible surfactants, as a vehicle or carrier for therapeutic drugs, which is substantially ethanol free and which can be administered to animals or humans various routes is disclosed. Also included in the emulsion is PEGylated vitamin E. PEGylated α-tocopherol includes polyethylene glycol subunits attached ... 06/30/05 - 20050142188 - Pellets having a core coated with an antifungal and a polymer The present invention is concerned with pellets comprising a 710-1180 μm (16-25 mesh) sugar core, a coating film of a water-soluble polymer and an antifungal agent, and a seal coating layer wherein the residual concentration of dichloromethane is below 600 ppm; pharmaceutical dosage forms comprising said pellets and a method ... 06/23/05 - 20050136104 - Chewable soft capsules containing ungelatinized starch A soft chewable capsule film suitable for medicament or foodstuff encapsulation, and a method of fabricating capsules from such a film. Such capsules demonstrate fast rupture in the oral cavity, good mouth feel and chewability, and rapid dissolution of the shell components. In particular, the modified starch is substantially ungelatinized, ... 06/09/05 - 20050123603 - Natural menaquinone 7 compositions The present invention relates to the field of human nutrition, and in particular to pharmaceutical compositions and nutritional supplements comprising an effective daily dose of menaquinone 7. In particular, the present invention provides pharmaceutical compositions, nutritional supplements and food products that comprise from about 10 to about 200 micrograms of ... ### FreshPatents.com Support |